Study #2018-0526
Open Labeled Placebo for treatment of Cancer Related Fatigue in Patients with Advanced Cancer
MD Anderson Study Status
Not Accepting
Treatment Agent
Description
This phase II/III trial studies an open labeled placebo to see how well it works compared with waitlist control in reducing cancer related fatigue in patients with cancer that has spread to other places in the body. A placebo is not a drug and is not designed to treat any disease or illness. Recent studies have found that cancer related fatigue symptoms in cancer survivors are improved with open labeled placebo (that is, patients know they are taking a placebo). It is not yet known how well an open labeled placebo works when compared with waitlist control in reducing cancer related fatigue.
Resources and Links
Phone Number: 1-877-MDA-6789
Information and next steps
Disease:
Advanced Malignant Solid Neoplasm;Metastatic Malignant Solid Neoplasm;Recurrent Malignant Solid Neoplasm
Study phase:
Phase II/III
Physician name:
Sriram Yennu
Department:
Palliative Care & Rehabilitation Medicine
For general questions about clinical trials:
1-844-635-1016
Help #EndCancer
Give Now
Donate Blood
Our patients depend on blood and platelet donations.
Shop MD Anderson
Show your support for our mission through branded merchandise.